The MAGGIC risk score in the prediction of death or hospitalization in patients with heart failure: Comparison with natriuretic peptides Felipe Mafort Rohen; Diane Xavier de Ávila; Carolina Martins Cabrita Lemos; Ricardo Santos; Mário Ribeiro; Humberto Villacorta;

Real-world dapagliflozin treatment patterns in Portuguese patients with heart failure with reduced ejection fraction Aurora Andrade; Sara Gonçalves; Ana Batista; Ana Teresa Timóteo; Ana Oliveira Soares; Fátima Franco; Otília Simões; Marisa Pardal; Mário Almeida; Margarida Lopes; Filipa Bernardo; José Silva Cardoso;

Dapagliflozin alleviates isoprenaline-induced cardiac hypertrophy by promoting mitophagy via AMPK¿2 signaling pathway Yue Feng; Zixiong Zhu; Xin Jing; Yibo Zhang; Yubin He; Xuewen Li;